Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27959700

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Feb 16
First author
Mok TS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2017 Feb;14(2):69. doi: 10.1038/nrclinonc.2016.220.
    note
    Source null
    related pmid
    28031555
    relationship
    Comment in
  2. citation
    Lancet Respir Med. 2017 Apr;5(4):251. doi: 10.1016/S2213-2600(17)30085-1.
    note
    Source null
    related pmid
    28284589
    relationship
    Comment in
  3. citation
    J Thorac Dis. 2017 Mar;9(3):470-473. doi: 10.21037/jtd.2017.03.26.
    note
    Source null
    related pmid
    28449447
    relationship
    Comment in
  4. citation
    N Engl J Med. 2017 May 18;376(20):1993. doi: 10.1056/NEJMc1703339.
    note
    Source null
    related pmid
    28514611
    relationship
    Comment in
  5. citation
    N Engl J Med. ;376(20):1992-3. doi: 10.1056/NEJMc1703339.
    note
    Source null
    related pmid
    28517914
    relationship
    Comment in
  6. citation
    Ann Transl Med. 2017 May;5(Suppl 1):S14. doi: 10.21037/atm.2017.03.73.
    note
    Source null
    related pmid
    28567396
    relationship
    Comment in

Authors and identifiers

  1. name
    Mok TS
    type
    Author
  2. name
    Wu Y-L
    type
    Author
  3. name
    Ahn M-J
    type
    Author
  4. name
    Garassino MC
    type
    Author
  5. name
    Kim HR
    type
    Author
  6. name
    Ramalingam SS
    type
    Author
  7. name
    Shepherd FA
    type
    Author
  8. name
    He Y
    type
    Author
  9. name
    Akamatsu H
    type
    Author
  10. name
    Theelen WS
    type
    Author
  11. name
    Lee CK
    type
    Author
  12. name
    Sebastian M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mok TS
    type
    Author
  2. name
    Wu Y-L
    type
    Author
  3. name
    Ahn M-J
    type
    Author
  4. name
    Garassino MC
    type
    Author
  5. name
    Kim HR
    type
    Author
  6. name
    Ramalingam SS
    type
    Author
  7. name
    Shepherd FA
    type
    Author
  8. name
    He Y
    type
    Author
  9. name
    Akamatsu H
    type
    Author
  10. name
    Theelen WS
    type
    Author
  11. name
    Lee CK
    type
    Author
  12. name
    Sebastian M
    type
    Author
bibliography ids
  1. nci-bib-c4703121d7623f9b4d85beb6
book metadata
content sha256
3c76de77e918e9efb38371c8b11b6db110745d28bedf298238ed862d6fc13148
document type
citation
dois
  1. 10.1056/NEJMoa1612674
electronic publication date
display
2016 Dec 6
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27959700
immutable id
pubmed:27959700@3c76de77e918e9efb38371c8b11b6db110745d28bedf298238ed862d6fc13148
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
7
name
The New England journal of medicine
nlm unique id
0255562
pages
629-640
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2017 Feb;14(2):69. doi: 10.1038/nrclinonc.2016.220.
    note
    Source null
    related pmid
    28031555
    relationship
    Comment in
  2. citation
    Lancet Respir Med. 2017 Apr;5(4):251. doi: 10.1016/S2213-2600(17)30085-1.
    note
    Source null
    related pmid
    28284589
    relationship
    Comment in
  3. citation
    J Thorac Dis. 2017 Mar;9(3):470-473. doi: 10.21037/jtd.2017.03.26.
    note
    Source null
    related pmid
    28449447
    relationship
    Comment in
  4. citation
    N Engl J Med. 2017 May 18;376(20):1993. doi: 10.1056/NEJMc1703339.
    note
    Source null
    related pmid
    28514611
    relationship
    Comment in
  5. citation
    N Engl J Med. ;376(20):1992-3. doi: 10.1056/NEJMc1703339.
    note
    Source null
    related pmid
    28517914
    relationship
    Comment in
  6. citation
    Ann Transl Med. 2017 May;5(Suppl 1):S14. doi: 10.21037/atm.2017.03.73.
    note
    Source null
    related pmid
    28567396
    relationship
    Comment in
outcomes validated
false
pmid
27959700
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
a9d1d5dad49d458539898e2510c0b3964fa41f55490db651c8de337f22cdc21a
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Feb 16
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27959700/
title
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Preserved source evidence · Not medical advice